Scandinavian Medical Solutions A/S

CPSE:SMSMED Stock Report

Market Cap: DKK 182.6m

Scandinavian Medical Solutions Past Earnings Performance

Past criteria checks 1/6

Scandinavian Medical Solutions has been growing earnings at an average annual rate of 5.5%, while the Healthcare industry saw earnings growing at 11.1% annually. Revenues have been growing at an average rate of 38.1% per year. Scandinavian Medical Solutions's return on equity is 9.4%, and it has net margins of 3.4%.

Key information

5.5%

Earnings growth rate

-67.2%

EPS growth rate

Healthcare Industry Growth13.4%
Revenue growth rate38.1%
Return on equity9.4%
Net Margin3.4%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Calculating The Fair Value Of Scandinavian Medical Solutions A/S (CPH:SMSMED)

Nov 03
Calculating The Fair Value Of Scandinavian Medical Solutions A/S (CPH:SMSMED)

Estimating The Intrinsic Value Of Scandinavian Medical Solutions A/S (CPH:SMSMED)

Jun 17
Estimating The Intrinsic Value Of Scandinavian Medical Solutions A/S (CPH:SMSMED)

Revenue & Expenses Breakdown

How Scandinavian Medical Solutions makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

CPSE:SMSMED Revenue, expenses and earnings (DKK Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 242278190
30 Jun 242127180
31 Mar 241985160
31 Dec 231949150
30 Sep 2319112140
30 Jun 2317314120
31 Mar 2315516110
31 Dec 221331490
30 Sep 221111170
30 Jun 2296960
31 Mar 2282750
31 Dec 2177840
30 Sep 2172830
30 Sep 2042510

Quality Earnings: SMSMED has a high level of non-cash earnings.

Growing Profit Margin: SMSMED's current net profit margins (3.4%) are lower than last year (6.4%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: SMSMED's earnings have grown by 5.5% per year over the past 5 years.

Accelerating Growth: SMSMED's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: SMSMED had negative earnings growth (-36.3%) over the past year, making it difficult to compare to the Healthcare industry average (15.6%).


Return on Equity

High ROE: SMSMED's Return on Equity (9.4%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies